Loading patent…
AssigneeInfinity Pharmaceuticals, Inc.
InventorsDaniel G. GENOV, Louis GRENIER, Andrew B. HAGUE, Alexander Redvers EBERLIN, Ludovic Sylvain Marc RENOU, Susana DEL RIO GANCEDO
Estimating the term…
Solid forms of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, solid forms thereof, and pharmaceutical compositions thereof.
A solid form comprising a compound of formula (I):
-6. (canceled)
-10. (canceled)
-16. (canceled)
-22. (canceled)
-26. (canceled)
-35. (canceled)
-39. (canceled)
-48. (canceled)
-52. (canceled)
-59. (canceled)
-64. (canceled)
-70. (canceled)
-75. (canceled)
-81. (canceled)
-86. (canceled)
-90. (canceled)
-95. (canceled)
-101. (canceled)
-107. (canceled)
-111. (canceled)
-116. (canceled)
-122. (canceled)
(canceled)
-139. (canceled)
A method preparing Form 1 of a sulfuric acid salt of Compound 1:
-148. (canceled)
Dependencies are inferred from the claim text.